Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Probiotics Dietary Supplements Market, by Form
1.4.2 Europe Probiotics Dietary Supplements Market, by End User
1.4.3 Europe Probiotics Dietary Supplements Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Acquisitions and Mergers
3.2.3 Product Launches and Product Expansions
3.2.4 Geographical Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2018, Apr – 2021, Sep) Leading Players
Chapter 4. Europe Probiotics Dietary Supplements Market by Form
4.1 Europe Capsules Market by Country
4.2 Europe Chewables & Gummies Market by Country
4.3 Europe Powders Market by Country
4.4 Europe Tablets & Softgels Market by Country
4.5 Europe Other Form Market by Country
Chapter 5. Europe Probiotics Dietary Supplements Market by End-user
5.1 Europe Adults Market by Country
5.2 Europe Geriatric Market by Country
5.3 Europe Children Market by Country
5.4 Europe Infants Market by Country
Chapter 6. Europe Probiotics Dietary Supplements Market by Country
6.1 Germany Probiotics Dietary Supplements Market
6.1.1 Germany Probiotics Dietary Supplements Market by Form
6.1.2 Germany Probiotics Dietary Supplements Market by End-user
6.2 UK Probiotics Dietary Supplements Market
6.2.1 UK Probiotics Dietary Supplements Market by Form
6.2.2 UK Probiotics Dietary Supplements Market by End-user
6.3 France Probiotics Dietary Supplements Market
6.3.1 France Probiotics Dietary Supplements Market by Form
6.3.2 France Probiotics Dietary Supplements Market by End-user
6.4 Russia Probiotics Dietary Supplements Market
6.4.1 Russia Probiotics Dietary Supplements Market by Form
6.4.2 Russia Probiotics Dietary Supplements Market by End-user
6.5 Spain Probiotics Dietary Supplements Market
6.5.1 Spain Probiotics Dietary Supplements Market by Form
6.5.2 Spain Probiotics Dietary Supplements Market by End-user
6.6 Italy Probiotics Dietary Supplements Market
6.6.1 Italy Probiotics Dietary Supplements Market by Form
6.6.2 Italy Probiotics Dietary Supplements Market by End-user
6.7 Rest of Europe Probiotics Dietary Supplements Market
6.7.1 Rest of Europe Probiotics Dietary Supplements Market by Form
6.7.2 Rest of Europe Probiotics Dietary Supplements Market by End-user
Chapter 7. Company Profiles
7.1 Koninklijke DSM N.V.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Acquisitions and Mergers:
7.1.5.2 Product Launches and Product Expansions:
7.2 DuPont de Nemours, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Partnerships, Collaborations, and Agreements:
7.2.5.2 Acquisition and Mergers:
7.2.5.3 Geographical Expansions:
7.2.5.4 Product Launches and Product Expansions:
7.3 Chr. Hansen Holding A/S
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Partnerships, Collaborations, and Agreements:
7.3.5.2 Acquisition and Mergers:
7.3.5.3 Product Launches and Product Expansions:
7.4 Archer Daniels Midland Company
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Partnerships, Collaborations, and Agreements:
7.4.5.2 Acquisition and Mergers:
7.4.5.3 Geographical Expansions:
7.5 Probi AB
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Partnerships, Collaborations, and Agreements:
7.5.5.2 Acquisition and Mergers:
7.6 BioGaia AB
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.6.5 Recent strategies and developments:
7.6.5.1 Partnerships, Collaborations, and Agreements:
7.7 Vitakem Nutraceutical, Inc.,
7.7.1 Company Overview
7.8 ProbioFerm
7.8.1 Company Overview
Unique Offerings 